Clinical Evidence

Over the 15 years of experience with the previous AA mixture, numerous experimental and clinical studies have been conducted and published in international peer-reviewed journals.

EAAs Supplementation: Mitochondrial Function and Clinical Outcomes

EAAs Supplementation: Mitochondrial Function and Clinical Outcomes Study: Protein malnutrition is the main determinant of frailty and sarcopenia in elderly people. Specific EAA mixture may contribute to slow-down mitochondrial dysfunction…

EAAs Against Development of Infection and as Immune-Modulators

EAAs Against Development of Infection and as Immune-Modulators Study: EAAs, included in the nutritional plan of patients in rehabilitation, are able to reduce the General Infection Rate. Design: 80 hospitalized…

Sarcopenia and Frailty

Sarcopenia and Frailty Age-associated loss of muscle mass and strength, with functional disabilities EAAs represent the most effective solution to provide energy for anabolic response EAAs long term supplementation may…

EAAs, Microbiota and Immunity

EAAs, Microbiota and Immunity Study: Metabolic shifts and structural changes in the gut microbiota upon amino acid supplementation. In order to slow down the ageing process. Design: Middle-aged mice (16…

EAAs or Dietary Proteins?

EAAs or Dietary Proteins? •In healthy elderly subjects the need for proteins is 1g/kg/day •In elderly ill subjects the need is about 1,5g/kg/d (**) 1.5 g/kg daily protein intake may…